Michelle Robertson

Former Executive Vice President and Chief Financial OfficeratEditas Medicine· In proxies 2021–2023

Pay in FY2023-54% from the year before · Editas Medicine stock +14.2% the same year

Michelle Robertson was paid $1.6M in FY2023 (Dec), down 54%. Editas Medicine stock rose 14.2% that year.

Pay$100 in the stock at the end of FY20 → $14

Pay is from the Summary Compensation Table of each Editas Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Editas MedicinePublic company · 5 yr
- Former Executive Vice President and Chief Financial Officer2021 – Present · 5 yrStock in role -96%

Roles come from the proxy statements of each company.

Activity

Pay
Editas Medicine Former CFO pay fell 54% to $1.6M. The stock rose 14% in FY2023 (Dec).
DEF 14AApr 16, 2024
Pay
Editas Medicine Former CFO pay rose 52% to $3.4M. The stock fell 67% in FY2022 (Dec).
DEF 14AApr 16, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?